23 Nov 2012 Lancet: Canada clamps down on access to drug safety data
Independent drug studies are under threat in Canada, say researchers whose access to government databases on drug safety and efficacy has been suspended. Paul Webster reports in the November 24, 2012 issue of the Lancet.
The Therapeutics Initiative is mentioned in the article and Dr. Jim Wright, Director of the Therapeutics Initiative, is quoted as saying “We’re in a survival mode”, because the provincial government has now suspended all data access despite the fact that none of the TI researchers have been named as part of the ongoing investigation. “We have a whole research team without any data access”, Wright explains. “We think we’re a casualty.” Wright worries that the decision to block the Initiative from access to data is part of “a continuum” that began in 2008 with the industry-supported efforts to dismantle it.